Fortress Biotech, Inc. (FBIO) Q4 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Fortress Biotech, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.193 Ladies and gentlemen, thank you for standing by. 00:00:03.193 -- 00:00:07.525 Good afternoon and welcome to Journey Medical's 2024 00:00:07.936 -- 00:00:11.279 Financial Results and Corporate Update Conference Call. 00:00:11.279 -- 00:00:15.181 At this time, all participants are in a listen-only mode. 00:00:15.181 -- 00:00:19.725 Should you need assistance, please signal a conference specialist by pressing the star 00:00:19.725 -- 00:00:25.309 key followed by zero. Participants of this call are advised that the audio 00:00:25.309 -- 00:00:30.574 of this conference call is being broadcast live over the internet and is also being 00:00:30.574 -- 00:00:36.057 recorded for playback purposes. A webcast replay of this call will be available 00:00:36.057 -- 00:00:42.009 approximately one hour after the end of the call for approximately 30 00:00:42.461 -- 00:00:43.881 days. 00:00:43.881 -- 00:00:49.085 I would now like to turn the call over to Jacqueline Jaffe, the company's Senior 00:00:49.085 -- 00:00:53.987 Director of Corporate Operations. Please go ahead. 00:00:53.987 -- 00:00:58.694 Good afternoon. And thank you for participating in today's conference call. 00:00:58.694 -- 00:01:03.836 Joining me from Journey Medical's leadership team are Claude Marawi, co-founder, president, 00:01:03.836 -- 00:01:08.598 and chief executive officer, and Joseph Banesh, chief financial officer. 00:01:08.598 -- 00:01:13.560 Joining for the Q&A portion of the call will be Ramzi Aloush, general counsel and corporate 00:01:13.560 -- 00:01:18.643 secretary, Dr. Srini Sidgiddi, vice president of research and development, 00:01:18.643 -- 00:01:22.803 and Louis Donati, director of market access. 00:01:22.803 -- 00:01:27.046 During this call, management will be...